Central actions of some beta-adrenoceptor blocking agents.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004597:Electroshock; D004983:Ethanolamines / Q000494:pharmacology; D004987:Ethers / Q000494:pharmacology; D007192:Indenes / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors; D009538:Nicotine / Q000037:antagonists & inhibitors; D009578:Nitrobenzenes / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010627:Phenethylamines / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011930:Reaction Time; D013015:Sotalol / Q000494:pharmacology; D013331:Strychnine / Q000037:antagonists & inhibitors
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D004987:Ethers; D007192:Indenes; D009578:Nitrobenzenes; D010627:Phenethylamines; D011412:Propanolamines; D009538:Nicotine; D009020:Morphine; D011433:Propranolol; D013015:Sotalol; D013331:Strychnine; D010424:Pentobarbital; D007545:Isoproterenol; D011217:Practolol; D003913:Dextroamphetamine; D010433:Pentylenetetrazole